Index RUT
P/E 48.30
EPS (ttm) 3.72
Insider Own 0.40%
Shs Outstand 32.51M
Perf Week -1.94%
Market Cap 5.85B
Forward P/E 36.82
EPS next Y 4.88
Insider Trans -10.02%
Shs Float 32.38M
Perf Month 4.56%
Income 121.54M
PEG 5.37
EPS next Q 1.10
Inst Own 89.99%
Short Float 1.37%
Perf Quarter 7.23%
Sales 942.38M
P/S 6.20
EPS this Y 8.88%
Inst Trans -0.52%
Short Ratio 3.96
Perf Half Y 15.02%
Book/sh 36.21
P/B 4.97
EPS next Y 12.17%
ROA 7.60%
Short Interest 0.44M
Perf Year 51.41%
Cash/sh 2.27
P/C 79.34
EPS next 5Y 9.00%
ROE 11.04%
52W Range 117.10 - 186.03
Perf YTD 20.91%
Dividend Est. -
P/FCF 35.96
EPS past 5Y 6.67%
ROI 8.56%
52W High -3.32%
Beta 0.66
Dividend TTM 0.79 (0.44%)
Quick Ratio 1.90
Sales past 5Y 7.74%
Gross Margin 34.47%
52W Low 53.59%
ATR (14) 4.38
Dividend Ex-Date Dec 26, 2023
Current Ratio 2.98
EPS Y/Y TTM 16.97%
Oper. Margin 20.80%
RSI (14) 58.96
Volatility 3.41% 2.29%
Employees 1302
Debt/Eq 0.21
Sales Y/Y TTM 1.74%
Profit Margin 12.90%
Recom 1.67
Target Price 190.33
Option/Short Yes / Yes
LT Debt/Eq 0.21
EPS Q/Q 15.28%
Payout 23.62%
Rel Volume 0.25
Prev Close 178.33
Sales Surprise -0.82%
EPS Surprise 1.35%
Sales Q/Q 4.35%
Earnings Oct 25 BMO
Avg Volume 111.76K
Price 179.85
SMA20 4.06%
SMA50 4.27%
SMA200 11.96%
Trades
Volume 4,219
Change 0.85%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-22-22 Upgrade
Sidoti
Neutral → Buy
$175
Nov-29-21 Downgrade
Sidoti
Buy → Neutral
$175
Aug-02-21 Downgrade
Stephens
Overweight → Equal-Weight
$140 → $145
Feb-22-21 Upgrade
Stephens
Equal-Weight → Overweight
Aug-04-20 Reiterated
H.C. Wainwright
Buy
$104 → $126
Jul-10-20 Initiated
Stephens
Equal-Weight
$100
Feb-24-20 Reiterated
H.C. Wainwright
Buy
$122 → $116
May-06-19 Downgrade
Pivotal Research Group
Buy → Hold
$100
Feb-21-19 Initiated
Seaport Global Securities
Neutral
Nov-06-18 Upgrade
Pivotal Research Group
Hold → Buy
$95 → $100
Oct-16-18 Upgrade
Sidoti
Neutral → Buy
Sep-25-18 Initiated
H.C. Wainwright
Buy
$140
Aug-03-18 Reiterated
Pivotal Research Group
Hold
$85 → $95
May-07-18 Upgrade
Pivotal Research Group
Sell → Hold
$85
Nov-04-16 Downgrade
Pivotal Research Group
Hold → Sell
$65 → $60
Mar-08-16 Downgrade
Sidoti
Buy → Neutral
Feb-02-16 Upgrade
Sidoti
Neutral → Buy
Apr-02-15 Initiated
Singular Research
Buy
$80
Jul-28-10 Initiated
DA Davidson
Neutral
Show Previous Ratings
Nov-01-24 07:00AM
Oct-30-24 09:40AM
Oct-26-24 07:00AM
Oct-25-24 07:06AM
(Associated Press Finance)
07:00AM
09:02AM
Loading…
Oct-24-24 09:02AM
Oct-11-24 07:00AM
Oct-09-24 03:19PM
Aug-23-24 07:00AM
Jul-26-24 07:09AM
(Associated Press Finance)
07:00AM
Jul-20-24 06:51AM
Jul-16-24 12:00PM
Jul-15-24 06:52AM
Jul-12-24 07:00AM
12:45PM
Loading…
Jul-11-24 12:45PM
08:50AM
Jun-26-24 07:00AM
May-29-24 07:00AM
May-21-24 08:52AM
07:00AM
May-13-24 07:01PM
04:22PM
May-10-24 07:00PM
May-06-24 08:45AM
May-04-24 09:11AM
May-03-24 08:32AM
08:04AM
07:04AM
(Associated Press Finance)
07:00AM
08:00AM
Loading…
May-02-24 08:00AM
May-01-24 07:00AM
Apr-26-24 10:00AM
Apr-22-24 07:00AM
Apr-19-24 07:00AM
Mar-28-24 08:50AM
Mar-27-24 09:40AM
Mar-11-24 09:40AM
08:50AM
Mar-06-24 11:31PM
Feb-29-24 07:00AM
Feb-27-24 11:22PM
Feb-23-24 11:24PM
Feb-22-24 09:40AM
Feb-18-24 08:19AM
Feb-16-24 07:32AM
07:15AM
(Associated Press Finance)
07:00AM
Feb-02-24 07:00AM
Jan-30-24 07:59AM
Jan-07-24 02:57PM
Dec-15-23 07:00AM
Dec-05-23 04:15PM
Oct-30-23 01:46AM
Oct-29-23 09:35AM
Oct-28-23 01:05AM
(Thomson Reuters StreetEvents)
Oct-27-23 10:06AM
07:12AM
(Associated Press Finance)
07:00AM
Oct-13-23 07:00AM
Jul-29-23 12:09PM
03:33AM
(Thomson Reuters StreetEvents)
Jul-28-23 07:10AM
(Associated Press Finance)
07:00AM
Jul-22-23 08:15AM
Jul-14-23 07:00AM
Jun-21-23 08:00PM
Jun-13-23 08:00AM
Jun-06-23 07:00AM
Jun-02-23 11:49AM
May-14-23 08:24AM
Apr-29-23 03:03AM
(Thomson Reuters StreetEvents)
Apr-28-23 07:17AM
07:00AM
Apr-27-23 07:15AM
Apr-26-23 08:00PM
07:00AM
Apr-25-23 07:31AM
Apr-14-23 07:00AM
Mar-27-23 07:58AM
Feb-28-23 08:49PM
Feb-26-23 07:32AM
Feb-25-23 03:42AM
(Thomson Reuters StreetEvents)
Feb-24-23 07:00AM
Feb-15-23 01:04PM
Feb-11-23 07:11AM
Feb-10-23 07:00AM
Jan-06-23 08:04AM
07:00AM
Jan-03-23 12:27PM
Dec-06-22 04:10PM
Nov-29-22 09:43AM
Nov-09-22 09:17AM
Nov-04-22 07:00AM
Oct-21-22 07:00AM
Oct-17-22 01:33PM
Sep-20-22 02:45PM
Sep-19-22 09:55AM
Sep-04-22 08:04AM
Aug-30-22 04:05PM
Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lee Joyce J. Former Director Nov 06 '24 Proposed Sale 180.87 4,476 809,565 Nov 06 04:49 PM Lee Joyce J. Former Director Nov 05 '24 Proposed Sale 175.00 2,000 350,000 Nov 05 05:33 PM van Gunsteren Job Leonard SVP and GM, Specialty Products Jul 31 '24 Option Exercise 59.65 7,750 462,268 16,290 Aug 02 06:08 PM van Gunsteren Job Leonard SVP and GM, Specialty Products Jul 31 '24 Sale 180.05 7,750 1,395,412 8,540 Aug 02 06:08 PM Backus William A. VP & Chief Accounting Officer Jul 30 '24 Option Exercise 84.09 3,900 327,951 8,888 Aug 01 06:09 PM Backus William A. VP & Chief Accounting Officer Jul 30 '24 Sale 179.35 3,900 699,465 4,988 Aug 01 06:09 PM Backus William A. VP & Chief Accounting Officer Jul 30 '24 Sale 177.10 904 160,094 132 Aug 01 06:09 PM van Gunsteren Job Leonard Officer Jul 31 '24 Proposed Sale 180.05 7,750 1,395,411 Jul 31 04:30 PM Backus William A. Officer Jul 30 '24 Proposed Sale 179.35 3,900 699,466 Jul 30 04:05 PM Sestrick Michael Robert SVP & Chief Technology Officer May 10 '24 Sale 154.45 1,929 297,935 4,878 May 13 04:15 PM Fischer David B Director May 08 '24 Sale 152.98 5,000 764,902 9,009 May 10 04:15 PM Tignor Michael Brent SVP & Chief HR Officer Mar 08 '24 Option Exercise 85.40 4,200 358,680 13,707 Mar 12 04:30 PM Tignor Michael Brent SVP & Chief HR Officer Mar 08 '24 Sale 157.52 5,339 840,985 8,368 Mar 12 04:30 PM Wineinger Matthew David Director Mar 04 '24 Sale 156.89 1,333 209,128 6,162 Mar 06 04:30 PM Backus William A. VP & Chief Accounting Officer Feb 23 '24 Option Exercise 80.44 9,180 738,421 22,094 Feb 27 04:58 PM Backus William A. VP & Chief Accounting Officer Feb 23 '24 Sale 156.37 9,180 1,435,469 12,914 Feb 27 04:58 PM Backus William A. VP & Chief Accounting Officer Feb 26 '24 Sale 155.19 7,000 1,086,304 5,914 Feb 27 04:58 PM Backus William A. VP & Chief Accounting Officer Feb 21 '24 Option Exercise 60.85 15,000 912,750 27,914 Feb 23 05:11 PM Backus William A. VP & Chief Accounting Officer Feb 21 '24 Sale 154.73 15,000 2,321,025 12,914 Feb 23 05:11 PM Sestrick Michael Robert SVP & Chief Technology Officer Feb 21 '24 Option Exercise 78.56 11,100 871,999 17,836 Feb 23 04:41 PM Sestrick Michael Robert SVP & Chief Technology Officer Feb 21 '24 Sale 153.21 11,100 1,700,613 6,736 Feb 23 04:41 PM Harris Theodore L Chairman, President & CEO Feb 22 '24 Option Exercise 59.11 34,350 2,030,398 100,762 Feb 23 04:37 PM Harris Theodore L Chairman, President & CEO Feb 22 '24 Sale 154.29 34,350 5,300,026 66,412 Feb 23 04:37 PM Harris Theodore L Chairman, President & CEO Feb 21 '24 Sale 153.58 29,679 4,558,031 66,412 Feb 23 04:37 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite